In addition, Ginsenoside Rh2 suppressed melanoma tumor growth and increased the survival in a B16F10 tumor model by enhancing CD4+ and CD8+ T cell infiltration into the tumor tissue [46]. This evidence concerns the gene CD4 and melanoma.